ModerateAntiplatelet agents – P2Y12 receptor inhibitors×Herbal agents for cognitive disorders
Updated · Methodology
Mechanism
Clopidogrel blocks the P2Y12 receptor and ginkgo inhibits platelet-activating factor. Both act on aggregation through different routes, and the European monograph names antiplatelet agents explicitly among treatments with increased bleeding risk.
Symptoms
Bruising, bleeding gums, prolonged bleeding after minor wounds.
Management
Inform the cardiologist or neurologist who prescribed clopidogrel. If ginkgo is being taken without a firm indication, stopping it is the simple option. On dual antiplatelet therapy after a stent the margin is smaller still, and prior consultation stops being optional.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- EMA: European Union herbal monograph on Ginkgo biloba L., folium (2015)– EMA/HMPC, final EU herbal monograph, Ginkgo biloba L., folium